by admin | Dec 14, 2017 | News
An EFRO TENDER VALORISATIE 2017 grant of a EUR 1.0 million cardiac fibrosis imaging program is awarded to BiOrion Technologies BV. The grant will be used for the preparation and execution of a clinical phase 0 imaging study in cardiac fibrosis patients and the...
by admin | Sep 26, 2017 | News
The EUROSTARS grant of a EUR 1.8 million fibrosis imaging program is awarded to a multidisciplinary consortium including BiOrion Technologies BV, Zealand Pharma A/S and Akademiska Sjukhuset, PET Centre, University Uppsala. EUROSTARS is a joint program between EUREKA...
by admin | Mar 13, 2017 | News
A VIA2016 grant of a EUR 50 thousand in fibrosis treatment is awarded to BiOrion Technologies BV. The grant will be used for the optimization of targeted interferon gamma in fibrosis with BiOrion’s PDGF beta receptor binding bicyclic peptide program. Fibrosis is...
by admin | Mar 6, 2017 | News
A VIA2016 grant of a EUR 50 thousand in hepatic fibrosis imaging is awarded to BiOrion Technologies BV. The grant will be used for the optimization of PET radio-tracers and optical tracers in fibrosis with BiOrion’s PDGF beta receptor binding bicyclic peptide...
by admin | Nov 11, 2016 | News
BiOrion Technologies BV has raised funding from Carduso Capital for its clinical validation program in fibrosis. BiOrion Technologies BV (BiOrion), a biopharmaceutical drug discovery company, develops products for the diagnosis and treatment of fibrosis. Fibrosis is a...
